{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:59:54Z","timestamp":1784156394619,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Centre of Postgraduate Medical Education","award":["501-1-54-01-17"],"award-info":[{"award-number":["501-1-54-01-17"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ijcard.2018.07.015","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T13:48:32Z","timestamp":1530625712000},"page":"283-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8298-9243","authenticated-orcid":false,"given":"Szymon","family":"Darocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Banaszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Pietrasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Pi\u0142ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Florczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wieteska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dobosiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Szmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Kurzyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijcard.2018.07.015_bb0005","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Galie","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.ijcard.2018.07.015_bb0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2018.07.015_bb0015","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1183\/09031936.00087114","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)","volume":"45","author":"Simonneau","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.ijcard.2018.07.015_bb0020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02425-2016","article-title":"RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors","volume":"50","author":"Hoeper","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.ijcard.2018.07.015_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/2045893217708566","article-title":"Phosphodiesterase type 5 inhibitor to riociguat transition is associated with hemodynamic and symptomatic improvement in pulmonary hypertension","volume":"7","author":"Davey","year":"2017","journal-title":"Pulm. Circ."},{"issue":"1","key":"10.1016\/j.ijcard.2018.07.015_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5603\/KP.2015.0011","article-title":"Summary of recommendations for the haemodynamic and angiographic assessment of the pulmonary circulation. Joint statement of the Polish Cardiac Society's Working Group on Pulmonary Circulation and Association of Cardiovascular Interventions","volume":"73","author":"Kurzyna","year":"2015","journal-title":"Kardiol. Pol."},{"issue":"5","key":"10.1016\/j.ijcard.2018.07.015_bb0035","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1183\/09031936.00105914","article-title":"PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension","volume":"45","author":"Galie","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.ijcard.2018.07.015_bb0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1076029614536604","article-title":"Outcome of medically versus surgically treated patients with chronic thromboembolic pulmonary hypertension","volume":"22","author":"Wieteska","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"5","key":"10.1016\/j.ijcard.2018.07.015_bb0045","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0003-4975(03)00828-2","article-title":"Pulmonary endarterectomy: experience and lessons learned in 1,500 cases","volume":"76","author":"Jamieson","year":"2003","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.ijcard.2018.07.015_bb0050","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jtcvs.2010.11.024","article-title":"Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry","volume":"141","author":"Mayer","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"18","key":"10.1016\/j.ijcard.2018.07.015_bb0055","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcard.2018.07.015_bb0060","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jcin.2014.06.010","article-title":"Pressure-wire-guided percutaneous transluminal pulmonary angioplasty: a breakthrough in catheter-interventional therapy for chronic thromboembolic pulmonary hypertension","volume":"7","author":"Inami","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"issue":"10","key":"10.1016\/j.ijcard.2018.07.015_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003318","article-title":"Novel angiographic classification of each vascular lesion in chronic thromboembolic pulmonary hypertension based on selective angiogram and results of balloon pulmonary angioplasty","volume":"9","author":"Kawakami","year":"2016","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"19","key":"10.1016\/j.ijcard.2018.07.015_bb0070","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/heartjnl-2012-303549","article-title":"Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension","volume":"99","author":"Andreassen","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2018.07.015_bb0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2015.01.034","article-title":"Additional percutaneous transluminal pulmonary angioplasty for residual or recurrent pulmonary hypertension after pulmonary endarterectomy","volume":"183","author":"Shimura","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2018.07.015_bb0080","first-page":"1","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension","volume":"11","author":"Kurzyna","year":"2015","journal-title":"Postepy Kardiol Interwencyjnej."},{"issue":"7","key":"10.1016\/j.ijcard.2018.07.015_bb0085","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5603\/KP.a2017.0091","article-title":"Changing the strategy of balloon pulmonary angioplasty resulted in a reduced complication rate in patients with chronic thromboembolic pulmonary hypertension. A single-centre European experience","volume":"75","author":"Kurzyna","year":"2017","journal-title":"Kardiol. Pol."},{"issue":"4","key":"10.1016\/j.ijcard.2018.07.015_bb0090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1253\/circj.CJ-16-1075","article-title":"Improvement in quality of life and hemodynamics in chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty","volume":"81","author":"Darocha","year":"2017","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.ijcard.2018.07.015_bb0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ijcard.2018.07.015_bb0100","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2018.07.015_bb0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1378\/chest.103.3.685","article-title":"Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension","volume":"103","author":"Moser","year":"1993","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ijcard.2018.07.015_bb0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/019021400404555","article-title":"Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase","volume":"26","author":"Kim","year":"2000","journal-title":"Exp. Lung Res."},{"issue":"4 Pt 1","key":"10.1016\/j.ijcard.2018.07.015_bb0115","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1164\/ajrccm.162.4.9912131","article-title":"Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study","volume":"162","author":"Yi","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"25","key":"10.1016\/j.ijcard.2018.07.015_bb0120","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2008.08.059","article-title":"Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial","volume":"52","author":"Jais","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.07.015_bb0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1378\/chest.07-2681","article-title":"Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension","volume":"134","author":"Suntharalingam","year":"2008","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.ijcard.2018.07.015_bb0130","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200210-1157BC","article-title":"Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension","volume":"167","author":"Ghofrani","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.ijcard.2018.07.015_bb0135","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1183\/09031936.00039007","article-title":"Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension","volume":"30","author":"Reichenberger","year":"2007","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.ijcard.2018.07.015_bb0140","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1378\/chest.128.4.2363","article-title":"Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension","volume":"128","author":"Hoeper","year":"2005","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.ijcard.2018.07.015_bb0145","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/thx.2005.046961","article-title":"Bosentan in inoperable chronic thromboembolic pulmonary hypertension","volume":"60","author":"Hughes","year":"2005","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.ijcard.2018.07.015_bb0150","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1378\/chest.128.4.2599","article-title":"Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension","volume":"128","author":"Bonderman","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijcard.2018.07.015_bb0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12890-017-0563-7","article-title":"Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study","volume":"17","author":"McLaughlin","year":"2017","journal-title":"BMC Pulm. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318314645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318314645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T17:20:09Z","timestamp":1541006409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318314645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":31,"alternative-id":["S0167527318314645"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.07.015","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}